Washington, DC – The National Institutes of Health (NIH) are embarking on a groundbreaking initiative to collect private medical records from various sources across the United States. These records will be used for a new autism study led by US Secretary of Health, Robert F Kennedy Jr.
In an effort to fulfill a controversial promise made by the Health Secretary to uncover the root cause of autism by September, the NIH is compiling data from federal and commercial databases. The goal is to create a comprehensive registry to track individuals with autism.
Despite skepticism from some experts about the feasibility of achieving such a complex task in a short timeframe, Dr. Peter Marks emphasized the challenges involved in obtaining definitive answers quickly. This skepticism was voiced during a recent appearance on CBS’s Face the Nation.
Director of NIH, Jay Bhattacharya, highlighted the importance of providing researchers with access to extensive patient data and health records to support studies on autism. The agency is exploring ways to streamline the collection of fragmented data resources from various sources across the country.
The study aims to incorporate medication records, lab testing, genomics data, as well as information from insurers and wearable technology such as smartwatches and fitness trackers. Between 10 and 20 research teams will receive grants to analyze this vast dataset.
Bhattacharya underscored the potential for real-time health monitoring beyond autism research, suggesting that the initiative could have broader implications for studying chronic diseases. While acknowledging Kennedy’s optimism about discovering answers by September, Bhattacharya emphasized that the research process would be ongoing and evolving.
Kennedy’s recent statements linking the rise in autism diagnoses to environmental toxins have sparked debate among health researchers. The NIH has been contacted by The Guardian for comment on this groundbreaking data collection initiative.









Lord Abbett High Yield Fund Q4 2025 Commentary: What Investors Need to Know for a Profitable Future!
Jersey City, New Jersey—In the closing quarters of 2025, Lord Abbett High Yield Fund navigated a challenging investment landscape, marked by evolving interest rates and shifting economic indicators. Analysts noted that despite initial obstacles, investors were encouraged by the fund’s strategic allocation and management decisions, which positioned it favorably amidst market uncertainty. The fund’s performance during the fourth quarter reflected a cautious but calculated approach to high-yield debt. With inflationary pressures beginning to stabilize, the fund’s managers focused on identifying opportunities in sectors that showed ... Read more